In a murine model, adoptive transfer of MHC-II-restricted TRP-specific TCR-engineered T cells induced tumor regression while MHC-I restricted TCR-transduced CD8+ T cells only delayed tumor growth35. This evidence concerns the gene CD8A and neoplasm.